The Role of Coenzyme Q10 in Statin-Associated Myopathy: A Systematic Review

This publication has 42 references indexed in Scilit:

• Effect of Ezetimibe and/or Simvastatin on Coenzyme Q10 Levels in Plasma
  Drug Safety, 2006
• Statin-associated neuromyotoxicity
  Drugs of Today, 2005
• Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction
  The American Journal of Cardiology, 2004
• Atorvastatin Decreases the Coenzyme Q10 Level in the Blood of Patients at Risk for Cardiovascular Disease and Stroke
  Archives of Neurology, 2004
• Cerivastatin and Reports of Fatal Rhabdomyolysis
  New England Journal of Medicine, 2002
• The effect of Simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle
  The American Journal of Cardiology, 1996
• Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors
  Molecular Aspects of Medicine, 1994
• Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin.
  Journal of Clinical Pathology, 1993
• Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled Study
  The Journal of Clinical Pharmacology, 1993
• Effects of mevinolin treatment on tissue dolichol and ubiquinone levels in the rat
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992